From Indulgence to 'Food as Medicine': Ice Cream's Shift

The traditional ice cream industry is navigating a challenging landscape marked by declining sales, influenced by the rise of weight loss drugs and a pervasive wellness culture emphasizing protein and fiber. Global ice cream sales, a £85bn market, saw a dip, with companies like Magnum reporting reduced sales in the last quarter of 2025. This downturn is partly attributed to the increasing popularity of GLP-1 drugs, such as Ozempic, which suppress appetite.

In response, manufacturers are innovating, with Magnum developing new ranges of protein- and vitamin-enriched lollies and tubs. These "functional" ice creams are designed to appeal to consumers who view food as medicine, prioritizing perceived health benefits over traditional indulgence. This strategic pivot aims to capture a market increasingly focused on ingredients, transparency, and nutritional value.

Experts express caution, noting that vitamin or protein claims on ice cream packaging may be misleading, as supplements often lack proven health benefits unless medically prescribed. Some ingredients used to replace sugar or enhance texture in "healthier" alternatives can also disrupt bodily signals and gut health. This suggests that while ice cream may adapt to market demands, its core identity as a pleasure-focused treat is being challenged.

Despite these trends, traditional ice cream parlours emphasizing fresh, non-ultra-processed ingredients and indulgent flavors continue to thrive. Their loyal customer base prioritizes rich taste and sensory pleasure, suggesting that the appetite for pure enjoyment remains strong. The future of ice cream may lie in a balance between indulgence and perceived wellness, or perhaps in distinct market segments catering to both desires.